The recent decision to launch vaccine trials in the Democratic Republic of Congo underscores the intricate challenges of combating Ebola during persistent conflict between government forces and rebel groups.
The M23 coalition, which seized Goma and Bukavu earlier in 2025, has attempted to showcase its governance capabilities by operating a parallel Ebola response in areas it controls.
In late June, rebel authorities announced that their territories had been declared Ebola‑free.
Ebola is a rare but severe viral disease, and the Bundibugyo strain is even more uncommon, with only two documented outbreaks to date.
Symptoms of Ebola can mimic those of flu or malaria, including fever, headache and fatigue, and may onset abruptly within two to 21 days after infection.
As the disease advances, patients may experience vomiting and diarrhea, potentially leading to organ failure. Transmission occurs through contact with infected bodily fluids such as blood or vomit.
Also Read
- Zoetis Grapples with U.S. Pet-Care Slowdown as Pipeline Hopes Hang in Balance
- Two Lives Lost, Five Injured as Giant Ganesha Idol Collapses onto Mumbai Crowd During Ganesh Chaturthi Procession
- Two Palestinians, Including a Minor, Killed in Israeli Airstrikes on Gaza Despite Ceasefire Agreement
- Viral ‘Cat in the Hat’ TikTok trend sparks fun fake videos but also real fear